Authors:
Havlir, DV
Bassett, R
Levitan, D
Gilbert, P
Tebas, P
Collier, AC
Hirsch, MS
Ignacio, C
Condra, J
Gunthard, HF
Richman, DD
Wong, JK
Citation: Dv. Havlir et al., Prevalence and predictive value of intermittent viremia with combination HIV therapy, J AM MED A, 286(2), 2001, pp. 171-179
Authors:
Para, MF
Glidden, DV
Coombs, RW
Collier, AC
Condra, JH
Craig, C
Bassett, R
Leavitt, R
Snyder, S
McAuliffe, V
Boucher, C
Citation: Mf. Para et al., Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS Clinical Trials Group protocol 333, J INFEC DIS, 182(3), 2000, pp. 733-743
Authors:
Friedland, GH
Pollard, R
Griffith, B
Hughes, M
Morse, G
Bassett, R
Freimuth, W
Demeter, L
Connick, E
Nevin, T
Hirsch, M
Fischl, M
Citation: Gh. Friedland et al., Efficacy and safety of delavirdine mesylate with zidovudine and didanosinecompared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm(3) (ACTG 261), J ACQ IMM D, 21(4), 1999, pp. 281-292
Authors:
Kuritzkes, DR
Marschner, I
Johnson, VA
Bassett, R
Eron, JJ
Fischl, MA
Murphy, RL
Fife, K
Maenza, J
Rosandich, ME
Bell, D
Wood, K
Sommadossi, JP
Pettinelli, C
Citation: Dr. Kuritzkes et al., Lamivudine in combination with zidovudine stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial, AIDS, 13(6), 1999, pp. 685-694